2.4.2.29	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32182756&form=6&db=m	tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors.	causal interaction,diagnostic usage,ongoing research,unassigned	4,1,4,0	
2.4.2.29	Carcinogenesis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32182756&form=6&db=m	tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors.	causal interaction,diagnostic usage,ongoing research,unassigned	4,1,4,0	
2.4.2.29	Colonic Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1378304&form=6&db=m	Absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line.	ongoing research,unassigned	4,0	
2.4.2.29	Colonic Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15246567&form=6&db=m	Elevated expression level of 60-kDa subunit of tRNA-guanine transglycosylase in colon cancer.	causal interaction,diagnostic usage,unassigned	2,3,0	
2.4.2.29	Dysentery, Bacillary	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11178905&form=6&db=m	A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase.	therapeutic application,unassigned	4,0	
2.4.2.29	Dysentery, Bacillary	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18510366&form=6&db=m	Structure-based drug design: exploring the proper filling of apolar pockets at enzyme active sites.	causal interaction,therapeutic application,unassigned	1,4,0	
2.4.2.29	Dysentery, Bacillary	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19199329&form=6&db=m	Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.	causal interaction,unassigned	1,0	
2.4.2.29	Dysentery, Bacillary	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19746363&form=6&db=m	High-Affinity Inhibitors of tRNA-Guanine Transglycosylase Replacing the Function of a Structural Water Cluster.	therapeutic application,unassigned	1,0	
2.4.2.29	Dysentery, Bacillary	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19894214&form=6&db=m	How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase.	therapeutic application,unassigned	4,0	
2.4.2.29	Dysentery, Bacillary	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23534552&form=6&db=m	Launching Spiking Ligands into a Protein-Protein Interface: A Promising Strategy to Destabilize and Break Interface Formation in a tRNA Modifying Enzyme.	therapeutic application,unassigned	3,0